Orgovyx

Active Ingredient(s): Relugolix
FDA Approved: * December 18, 2020
Pharm Company: * MYOVANT SCIENCES
Category: Cancer

Relugolix, sold under the brand names Orgovyx and Relumina, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication which is used in the treatment of prostate cancer in men and uterine fibroids in women.[2][3][4][1] It is also under development for use in the treatment of endometriosis.[3][5][6][7][8][9]&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.